NCT04762602CompletedPhase 1
A Phase 1 Study of HMPL-306 in Locally Advanced Solid Tumors with IDH mutations
Source: EU CTIS (euclinicaltrials.eu) · Last updated 4 Sept 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- First submitted
- 2 Sept 2024
- Start date
- 9 Feb 2021
- Lead sponsor
- Hutchmed Ltd.
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT04762602
- EU CT number
- 2024-516370-30-00
- EudraCT number
- 2020-003729-44
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 24
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitari Vall d'Hebron Coordinator of this site? Confirm its status | Barcelona | Spain | Completed |
| Hospital Universitario 12 de Octubre Coordinator of this site? Confirm its status | Madrid | Spain | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.